0.021209
0.012245
0.000000
0.000000
0.024490
0.000000
0.000000
0.000000
0.004883
0.00000
0.00000
0.00000
Hatanaka, H.
Iourin, O.
Rao, Z.
Fry, E.
Kingsman, A.
Stuart, D.I.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
12
90.00
90.00
120.00
47.150
47.150
204.770
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H11 N O2 Se
196.106
n
SELENOMETHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Virol.
JOVIAM
0825
0022-538X
76
1876
10.1128/JVI.76.4.1876-1883.2002
11799182
Structure of Equine Infectious Anemia Virus Matrix Protein.
2002
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100.0
1
IMAGE PLATE
1998-04-15
MARRESEARCH
MAD
M
x-ray
1
0.9116
1.0
0.9781
1.0
0.9778
1.0
BM14
ESRF
0.9116, 0.9781, 0.9778
SYNCHROTRON
ESRF BEAMLINE BM14
THE PROTEIN HAS AN N-TERMINAL EXTENTION OF SEVEN RESIDUES DUE TO THE EXPRESSION CONSTRUCT.
15022.591
GAG POLYPROTEIN, CORE PROTEIN P15
MA PROTEIN
2
man
polymer
EIAV MA, MATRIX PROTEIN, P15
no
yes
A(MSE)ADIGS(MSE)GDPLTWSKALKKLEKVTVQGSQKLTTGNCNWALSLVDLFHDTNFVKEKDWQLRDVIPLLEDVTQ
TLSGQEREAFERTWWAISAVK(MSE)GLQINNVVDGKASFQLLRAKYEKKTANKKQSEPSEEY
AMADIGSMGDPLTWSKALKKLEKVTVQGSQKLTTGNCNWALSLVDLFHDTNFVKEKDWQLRDVIPLLEDVTQTLSGQERE
AFERTWWAISAVKMGLQINNVVDGKASFQLLRAKYEKKTANKKQSEPSEEY
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
EIAV
ISOLATE WYOMING
sample
GAG
11665
EQUINE INFECTIOUS ANEMIA VIRUS
CLONE P3.2-1
469008
ESCHERICHIA COLI
BL21(DE3)
PLASMID
PET-32A
1
2.55
51.43
FIGURES ARE SHOWN FOR THE WAVELENGTH 0.91116.
6.50
30% PEG5000, 0.2M AMMONIUM SULFATE, 0.1M MES (PH6.5), 291K, pH 6.50
291
exptl_crystal_grow
pdbx_database_proc
pdbx_database_status
struct_conn
repository
Initial release
Version format compliance
Version format compliance
Data collection
Derived calculations
Experimental preparation
Other
1
0
2001-11-23
1
1
2011-05-08
1
2
2011-07-13
1
3
2019-05-22
_exptl_crystal_grow.temp
_pdbx_database_status.recvd_author_approval
_struct_conn.pdbx_leaving_atom_flag
X-RAY CRYSTAL STRUCTURE OF EQUINE INFECTIOUS ANEMIA VIRUS(EIAV) CAPSID PROTEIN P26
X-RAY CRYSTAL STRUCTURE OF EQUINE INFECTIOUS ANEMIA VIRUS(EIAV) CAPSID PROTEIN P26
HELIX
DETERMINATION METHOD: AUTHOR PROVIDED.
PDBE
Y
PDBE
2000-11-24
REL
RESIDUES -6 TO 0 ARE A CLONING ARTIFACT
ALA
-6
n
1
ALA
-6
A
MSE
-5
n
2
MSE
-5
A
ALA
-4
n
3
ALA
-4
A
ASP
-3
n
4
ASP
-3
A
ILE
-2
n
5
ILE
-2
A
GLY
-1
n
6
GLY
-1
A
SER
0
n
7
SER
0
A
MSE
1
n
8
MSE
1
A
GLY
2
n
9
GLY
2
A
ASP
3
n
10
ASP
3
A
PRO
4
n
11
PRO
4
A
LEU
5
n
12
LEU
5
A
THR
6
n
13
THR
6
A
TRP
7
n
14
TRP
7
A
SER
8
n
15
SER
8
A
LYS
9
n
16
LYS
9
A
ALA
10
n
17
ALA
10
A
LEU
11
n
18
LEU
11
A
LYS
12
n
19
LYS
12
A
LYS
13
n
20
LYS
13
A
LEU
14
n
21
LEU
14
A
GLU
15
n
22
GLU
15
A
LYS
16
n
23
LYS
16
A
VAL
17
n
24
VAL
17
A
THR
18
n
25
THR
18
A
VAL
19
n
26
VAL
19
A
GLN
20
n
27
GLN
20
A
GLY
21
n
28
GLY
21
A
SER
22
n
29
SER
22
A
GLN
23
n
30
GLN
23
A
LYS
24
n
31
LYS
24
A
LEU
25
n
32
LEU
25
A
THR
26
n
33
THR
26
A
THR
27
n
34
THR
27
A
GLY
28
n
35
GLY
28
A
ASN
29
n
36
ASN
29
A
CYS
30
n
37
CYS
30
A
ASN
31
n
38
ASN
31
A
TRP
32
n
39
TRP
32
A
ALA
33
n
40
ALA
33
A
LEU
34
n
41
LEU
34
A
SER
35
n
42
SER
35
A
LEU
36
n
43
LEU
36
A
VAL
37
n
44
VAL
37
A
ASP
38
n
45
ASP
38
A
LEU
39
n
46
LEU
39
A
PHE
40
n
47
PHE
40
A
HIS
41
n
48
HIS
41
A
ASP
42
n
49
ASP
42
A
THR
43
n
50
THR
43
A
ASN
44
n
51
ASN
44
A
PHE
45
n
52
PHE
45
A
VAL
46
n
53
VAL
46
A
LYS
47
n
54
LYS
47
A
GLU
48
n
55
GLU
48
A
LYS
49
n
56
LYS
49
A
ASP
50
n
57
ASP
50
A
TRP
51
n
58
TRP
51
A
GLN
52
n
59
GLN
52
A
LEU
53
n
60
LEU
53
A
ARG
54
n
61
ARG
54
A
ASP
55
n
62
ASP
55
A
VAL
56
n
63
VAL
56
A
ILE
57
n
64
ILE
57
A
PRO
58
n
65
PRO
58
A
LEU
59
n
66
LEU
59
A
LEU
60
n
67
LEU
60
A
GLU
61
n
68
GLU
61
A
ASP
62
n
69
ASP
62
A
VAL
63
n
70
VAL
63
A
THR
64
n
71
THR
64
A
GLN
65
n
72
GLN
65
A
THR
66
n
73
THR
66
A
LEU
67
n
74
LEU
67
A
SER
68
n
75
SER
68
A
GLY
69
n
76
GLY
69
A
GLN
70
n
77
GLN
70
A
GLU
71
n
78
GLU
71
A
ARG
72
n
79
ARG
72
A
GLU
73
n
80
GLU
73
A
ALA
74
n
81
ALA
74
A
PHE
75
n
82
PHE
75
A
GLU
76
n
83
GLU
76
A
ARG
77
n
84
ARG
77
A
THR
78
n
85
THR
78
A
TRP
79
n
86
TRP
79
A
TRP
80
n
87
TRP
80
A
ALA
81
n
88
ALA
81
A
ILE
82
n
89
ILE
82
A
SER
83
n
90
SER
83
A
ALA
84
n
91
ALA
84
A
VAL
85
n
92
VAL
85
A
LYS
86
n
93
LYS
86
A
MSE
87
n
94
MSE
87
A
GLY
88
n
95
GLY
88
A
LEU
89
n
96
LEU
89
A
GLN
90
n
97
GLN
90
A
ILE
91
n
98
ILE
91
A
ASN
92
n
99
ASN
92
A
ASN
93
n
100
ASN
93
A
VAL
94
n
101
VAL
94
A
VAL
95
n
102
VAL
95
A
ASP
96
n
103
ASP
96
A
GLY
97
n
104
GLY
97
A
LYS
98
n
105
LYS
98
A
ALA
99
n
106
ALA
99
A
SER
100
n
107
SER
100
A
PHE
101
n
108
PHE
101
A
GLN
102
n
109
GLN
102
A
LEU
103
n
110
LEU
103
A
LEU
104
n
111
LEU
104
A
ARG
105
n
112
ARG
105
A
ALA
106
n
113
ALA
106
A
LYS
107
n
114
LYS
107
A
TYR
108
n
115
TYR
108
A
GLU
109
n
116
GLU
109
A
n
117
110
A
n
118
111
A
n
119
112
A
n
120
113
A
n
121
114
A
n
122
115
A
n
123
116
A
n
124
117
A
n
125
118
A
n
126
119
A
n
127
120
A
n
128
121
A
n
129
122
A
n
130
123
A
n
131
124
A
ALA
-6
n
1
ALA
-6
B
MSE
-5
n
2
MSE
-5
B
ALA
-4
n
3
ALA
-4
B
ASP
-3
n
4
ASP
-3
B
ILE
-2
n
5
ILE
-2
B
GLY
-1
n
6
GLY
-1
B
SER
0
n
7
SER
0
B
MSE
1
n
8
MSE
1
B
GLY
2
n
9
GLY
2
B
ASP
3
n
10
ASP
3
B
PRO
4
n
11
PRO
4
B
LEU
5
n
12
LEU
5
B
THR
6
n
13
THR
6
B
TRP
7
n
14
TRP
7
B
SER
8
n
15
SER
8
B
LYS
9
n
16
LYS
9
B
ALA
10
n
17
ALA
10
B
LEU
11
n
18
LEU
11
B
LYS
12
n
19
LYS
12
B
LYS
13
n
20
LYS
13
B
LEU
14
n
21
LEU
14
B
GLU
15
n
22
GLU
15
B
LYS
16
n
23
LYS
16
B
VAL
17
n
24
VAL
17
B
THR
18
n
25
THR
18
B
VAL
19
n
26
VAL
19
B
GLN
20
n
27
GLN
20
B
GLY
21
n
28
GLY
21
B
SER
22
n
29
SER
22
B
GLN
23
n
30
GLN
23
B
LYS
24
n
31
LYS
24
B
LEU
25
n
32
LEU
25
B
THR
26
n
33
THR
26
B
THR
27
n
34
THR
27
B
GLY
28
n
35
GLY
28
B
ASN
29
n
36
ASN
29
B
CYS
30
n
37
CYS
30
B
ASN
31
n
38
ASN
31
B
TRP
32
n
39
TRP
32
B
ALA
33
n
40
ALA
33
B
LEU
34
n
41
LEU
34
B
SER
35
n
42
SER
35
B
LEU
36
n
43
LEU
36
B
VAL
37
n
44
VAL
37
B
ASP
38
n
45
ASP
38
B
LEU
39
n
46
LEU
39
B
PHE
40
n
47
PHE
40
B
HIS
41
n
48
HIS
41
B
ASP
42
n
49
ASP
42
B
THR
43
n
50
THR
43
B
ASN
44
n
51
ASN
44
B
PHE
45
n
52
PHE
45
B
VAL
46
n
53
VAL
46
B
LYS
47
n
54
LYS
47
B
GLU
48
n
55
GLU
48
B
LYS
49
n
56
LYS
49
B
ASP
50
n
57
ASP
50
B
TRP
51
n
58
TRP
51
B
GLN
52
n
59
GLN
52
B
LEU
53
n
60
LEU
53
B
ARG
54
n
61
ARG
54
B
ASP
55
n
62
ASP
55
B
VAL
56
n
63
VAL
56
B
ILE
57
n
64
ILE
57
B
PRO
58
n
65
PRO
58
B
LEU
59
n
66
LEU
59
B
LEU
60
n
67
LEU
60
B
GLU
61
n
68
GLU
61
B
ASP
62
n
69
ASP
62
B
VAL
63
n
70
VAL
63
B
THR
64
n
71
THR
64
B
GLN
65
n
72
GLN
65
B
THR
66
n
73
THR
66
B
LEU
67
n
74
LEU
67
B
SER
68
n
75
SER
68
B
GLY
69
n
76
GLY
69
B
GLN
70
n
77
GLN
70
B
GLU
71
n
78
GLU
71
B
ARG
72
n
79
ARG
72
B
GLU
73
n
80
GLU
73
B
ALA
74
n
81
ALA
74
B
PHE
75
n
82
PHE
75
B
GLU
76
n
83
GLU
76
B
ARG
77
n
84
ARG
77
B
THR
78
n
85
THR
78
B
TRP
79
n
86
TRP
79
B
TRP
80
n
87
TRP
80
B
ALA
81
n
88
ALA
81
B
ILE
82
n
89
ILE
82
B
SER
83
n
90
SER
83
B
ALA
84
n
91
ALA
84
B
VAL
85
n
92
VAL
85
B
LYS
86
n
93
LYS
86
B
MSE
87
n
94
MSE
87
B
GLY
88
n
95
GLY
88
B
LEU
89
n
96
LEU
89
B
GLN
90
n
97
GLN
90
B
ILE
91
n
98
ILE
91
B
ASN
92
n
99
ASN
92
B
ASN
93
n
100
ASN
93
B
VAL
94
n
101
VAL
94
B
VAL
95
n
102
VAL
95
B
ASP
96
n
103
ASP
96
B
GLY
97
n
104
GLY
97
B
LYS
98
n
105
LYS
98
B
ALA
99
n
106
ALA
99
B
SER
100
n
107
SER
100
B
PHE
101
n
108
PHE
101
B
GLN
102
n
109
GLN
102
B
LEU
103
n
110
LEU
103
B
LEU
104
n
111
LEU
104
B
ARG
105
n
112
ARG
105
B
ALA
106
n
113
ALA
106
B
LYS
107
n
114
LYS
107
B
TYR
108
n
115
TYR
108
B
GLU
109
n
116
GLU
109
B
n
117
110
B
n
118
111
B
n
119
112
B
n
120
113
B
n
121
114
B
n
122
115
B
n
123
116
B
n
124
117
B
n
125
118
B
n
126
119
B
n
127
120
B
n
128
121
B
n
129
122
B
n
130
123
B
n
131
124
B
software_defined_assembly
PQS
1
monomeric
software_defined_assembly
PQS
1
monomeric
A
MSE
-5
SELENOMETHIONINE
A
MSE
2
MET
A
MSE
1
SELENOMETHIONINE
A
MSE
8
MET
A
MSE
87
SELENOMETHIONINE
A
MSE
94
MET
B
MSE
-5
SELENOMETHIONINE
B
MSE
2
MET
B
MSE
1
SELENOMETHIONINE
B
MSE
8
MET
B
MSE
87
SELENOMETHIONINE
B
MSE
94
MET
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
LYS
110
A
LYS
117
1
Y
1
A
LYS
111
A
LYS
118
1
Y
1
A
THR
112
A
THR
119
1
Y
1
A
ALA
113
A
ALA
120
1
Y
1
A
ASN
114
A
ASN
121
1
Y
1
A
LYS
115
A
LYS
122
1
Y
1
A
LYS
116
A
LYS
123
1
Y
1
A
GLN
117
A
GLN
124
1
Y
1
A
SER
118
A
SER
125
1
Y
1
A
GLU
119
A
GLU
126
1
Y
1
A
PRO
120
A
PRO
127
1
Y
1
A
SER
121
A
SER
128
1
Y
1
A
GLU
122
A
GLU
129
1
Y
1
A
GLU
123
A
GLU
130
1
Y
1
A
TYR
124
A
TYR
131
1
Y
1
B
LYS
110
B
LYS
117
1
Y
1
B
LYS
111
B
LYS
118
1
Y
1
B
THR
112
B
THR
119
1
Y
1
B
ALA
113
B
ALA
120
1
Y
1
B
ASN
114
B
ASN
121
1
Y
1
B
LYS
115
B
LYS
122
1
Y
1
B
LYS
116
B
LYS
123
1
Y
1
B
GLN
117
B
GLN
124
1
Y
1
B
SER
118
B
SER
125
1
Y
1
B
GLU
119
B
GLU
126
1
Y
1
B
PRO
120
B
PRO
127
1
Y
1
B
SER
121
B
SER
128
1
Y
1
B
GLU
122
B
GLU
129
1
Y
1
B
GLU
123
B
GLU
130
1
Y
1
B
TYR
124
B
TYR
131
1
Y
1
B
B
OD1
OG1
ASP
THR
38
43
2.09
1
A
A
O
N
TRP
ALA
79
81
2.13
1
A
A
O
OG
GLY
SER
97
100
2.18
1
A
MSE
-5
-121.28
-168.05
1
A
ASP
-3
-78.43
35.32
1
A
ILE
-2
18.48
-73.63
1
A
SER
0
-141.50
-8.31
1
A
MSE
1
30.06
11.80
1
A
PRO
4
-44.41
-72.35
1
A
LEU
11
-49.61
-71.69
1
A
LYS
12
-32.77
-73.95
1
A
THR
18
-54.58
-173.36
1
A
GLN
20
-31.56
-116.53
1
A
SER
22
-174.48
44.71
1
A
LYS
24
-61.54
-171.05
1
A
CYS
30
-66.92
-71.81
1
A
ASN
31
-39.51
-27.01
1
A
THR
43
-84.61
-159.59
1
A
ASN
44
-155.06
34.78
1
A
TRP
51
173.96
155.23
1
A
LEU
60
-36.70
-70.12
1
A
GLU
61
-24.06
-49.97
1
A
GLN
70
-34.37
-30.01
1
A
GLU
71
-37.24
-37.27
1
A
ARG
72
-62.49
-74.30
1
A
TRP
80
-20.51
-49.53
1
A
ALA
81
-68.08
-84.70
1
A
MSE
87
-84.36
38.31
1
A
ASN
93
172.94
155.93
1
A
VAL
94
-60.67
-97.33
1
A
VAL
95
-13.54
-56.83
1
A
ASP
96
-62.09
98.39
1
A
ALA
99
-52.46
-78.35
1
A
SER
100
-24.90
-44.94
1
A
PHE
101
-58.30
-73.86
1
A
GLN
102
-26.80
-53.65
1
A
ARG
105
-75.95
-70.67
1
B
MSE
-5
-87.65
-130.64
1
B
ASP
-3
161.15
122.89
1
B
PRO
4
-49.37
-83.67
1
B
GLU
15
-46.31
-85.90
1
B
LYS
16
-20.66
-20.81
1
B
VAL
19
-113.15
-79.94
1
B
GLN
20
-84.25
-83.83
1
B
LEU
34
-68.16
5.17
1
B
LEU
39
-65.04
-72.07
1
B
PHE
40
-48.54
-78.63
1
B
ASP
42
52.90
101.72
1
B
THR
43
-156.17
-150.61
1
B
ASN
44
-143.16
-33.26
1
B
PHE
45
9.20
-79.60
1
B
LEU
60
-22.85
-36.41
1
B
LEU
67
-53.51
170.60
1
B
GLU
71
-60.27
-70.73
1
B
GLU
73
-24.29
-79.36
1
B
TRP
80
-38.88
-32.88
1
B
ALA
84
-55.45
-76.78
1
B
MSE
87
-74.03
26.49
1
B
VAL
94
-18.29
-51.99
1
B
ASP
96
-26.66
-50.06
1
B
ALA
99
-41.16
-81.35
1
B
SER
100
-24.98
-42.55
1
B
PHE
101
-71.58
-84.42
1
B
GLN
102
-27.98
-40.03
1
B
LEU
103
-60.00
-81.79
1
B
LEU
104
-35.16
-29.83
1
B
TYR
108
-100.12
67.75
PROTEIN_REP.PARAM
PROTEIN.TOP
79.4
22.08
24.47
0.00
22.08
0.00
-44.15
THE C-TERMINAL RESIDUES 110 TO 124 WERE NOT SEEN IN THE DENSITY MAPS
0.373
0.014
0.279
0.279
2.80
23.78
671
6153
10.9
97.2
RANDOM
0.000000
1
RESTRAINED
THROUGHOUT
0.0
MAD
FLAT MODEL
50
0.26
0.70
0.56
5.00
1.14
0.88
2.80
23.78
0
1844
0
0
1844
0.015
1.7
21.5
0.93
2.06
3.00
3.64
4.00
2.81
4.00
4.50
5.00
0.587
0.055
0.458
2.98
115
783
6
12.8
85.1
27.6
2.800
24.000
1HEK
6347
0.07400
1
11.4000
3.000
99.0
0.60000
2.80
2.90
1
2.80
99.0
refinement
CNS
1.0
data reduction
DENZO
data scaling
SCALEPACK
phasing
SHARP
GAG POLYPROTEIN, CORE PROTEIN P15
Crystal structure of equine infectious anaemia virus matrix antigen (EIAV MA)
1
N
N
1
N
N
A
THR
6
A
THR
13
HELX_P
A
VAL
17
A
VAL
24
1
1
12
A
THR
26
A
THR
33
HELX_P
A
HIS
41
A
HIS
48
1
2
16
A
GLN
52
A
GLN
59
HELX_P
A
GLN
65
A
GLN
72
1
3
14
A
GLN
70
A
GLN
77
HELX_P
A
MSE
87
A
MSE
94
1
4
18
A
GLY
97
A
GLY
104
HELX_P
A
GLU
109
A
GLU
116
1
5
13
B
THR
6
B
THR
13
HELX_P
B
GLU
15
B
GLU
22
1
6
10
B
THR
26
B
THR
33
HELX_P
B
HIS
41
B
HIS
48
1
7
16
B
ASN
44
B
ASN
51
HELX_P
B
GLU
48
B
GLU
55
5
8
5
B
GLN
52
B
GLN
59
HELX_P
B
GLN
65
B
GLN
72
1
9
14
B
GLY
69
B
GLY
76
HELX_P
B
MSE
87
B
MSE
94
1
10
19
B
VAL
94
B
VAL
101
HELX_P
B
ASP
96
B
ASP
103
5
11
3
B
GLY
97
B
GLY
104
HELX_P
B
LYS
107
B
LYS
114
1
12
11
covale
1.329
both
A
ALA
-6
A
C
ALA
1
1_555
A
MSE
-5
A
N
MSE
2
1_555
covale
1.334
both
A
MSE
-5
A
C
MSE
2
1_555
A
ALA
-4
A
N
ALA
3
1_555
covale
1.339
both
A
SER
0
A
C
SER
7
1_555
A
MSE
1
A
N
MSE
8
1_555
covale
1.329
both
A
MSE
1
A
C
MSE
8
1_555
A
GLY
2
A
N
GLY
9
1_555
covale
1.331
both
A
LYS
86
A
C
LYS
93
1_555
A
MSE
87
A
N
MSE
94
1_555
covale
1.329
both
A
MSE
87
A
C
MSE
94
1_555
A
GLY
88
A
N
GLY
95
1_555
covale
1.330
both
B
MSE
-5
B
C
MSE
2
1_555
B
ALA
-4
B
N
ALA
3
1_555
covale
1.330
both
B
ALA
-6
B
C
ALA
1
1_555
B
MSE
-5
B
N
MSE
2
1_555
covale
1.334
both
B
SER
0
B
C
SER
7
1_555
B
MSE
1
B
N
MSE
8
1_555
covale
1.333
both
B
MSE
1
B
C
MSE
8
1_555
B
GLY
2
B
N
GLY
9
1_555
covale
1.332
both
B
LYS
86
B
C
LYS
93
1_555
B
MSE
87
B
N
MSE
94
1_555
covale
1.335
both
B
MSE
87
B
C
MSE
94
1_555
B
GLY
88
B
N
GLY
95
1_555
VIRAL PROTEIN
VIRAL PROTEIN, MEMBRANE-BINDING SWITCHING
given
0.898050
-0.436290
0.056170
0.439150
0.896610
-0.056820
-0.025580
0.075700
0.996800
11.22631
21.75827
-18.20185
1HEK
PDB
1
1HEK
GAG_EIAVY
UNP
1
P03351
-6
0
1HEK
-6
0
1HEK
A
1
1
7
1
124
1HEK
1
124
P03351
A
2
8
131
-6
0
1HEK
-6
0
1HEK
B
1
1
7
1
124
1HEK
1
124
P03351
B
2
8
131
1
MET
modified residue
MSE
-5
1HEK
A
1HEK
PDB
-5
2
1
MET
modified residue
MSE
1
1HEK
A
P03351
UNP
1
8
1
MET
modified residue
MSE
87
1HEK
A
P03351
UNP
87
94
3
MET
modified residue
MSE
-5
1HEK
B
1HEK
PDB
-5
2
3
MET
modified residue
MSE
1
1HEK
B
P03351
UNP
1
8
3
MET
modified residue
MSE
87
1HEK
B
P03351
UNP
87
94
170
P 65